Cargando…
An evaluation of the benefits and harms of antenatal corticosteroid treatment for women at risk of imminent preterm birth or prior to elective Caesarean-section: Study protocol for an individual participant data meta-analysis
Background: Antenatal corticosteroid treatment (ACT) has been widely accepted as a safe, beneficial treatment which improves outcomes following preterm birth. It has been shown to reduce respiratory distress syndrome and neonatal mortality and is commonly used in threatened or planned preterm delive...
Autores principales: | Wastnedge, Elizabeth, Vogel, Joshua, Been, Jasper V., Bannerman-Gyamfi, Cynthia, Schuit, Ewoud, Roberts, Devender, Reynolds, Rebecca M., Stock, Sarah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268149/ https://www.ncbi.nlm.nih.gov/pubmed/32529039 http://dx.doi.org/10.12688/wellcomeopenres.15661.1 |
Ejemplares similares
-
Consortium for the Study of Pregnancy Treatments (Co-OPT): An international birth cohort to study the effects of antenatal corticosteroids
por: Frier, Emily M., et al.
Publicado: (2023) -
Practice patterns in the administration of late preterm antenatal corticosteroids
por: Gulersen, Moti, et al.
Publicado: (2021) -
Antenatal Corticosteroids: Extending the Practice for Late-Preterm and Scheduled Early-Term Deliveries?
por: Htun, Zeyar T., et al.
Publicado: (2021) -
Antenatal corticosteroids for women at risk of imminent preterm birth in low-resource countries: the case for equipoise and the need for efficacy trials
por: Vogel, Joshua P, et al.
Publicado: (2017) -
Antenatal corticosteroids and COVID-19: balancing benefits and harms
por: Liauw, Jessica, et al.
Publicado: (2020)